Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand.
Onwipa RochanathimokeArthorn RiewpaiboonNaiyana PraditsitthikornPiyanit TharmaphornpilasSuchada JiamsiriMontarat ThavorncharoensapMaarten Jacobus PostmaPublished in: Expert review of pharmacoeconomics & outcomes research (2021)
Incorporating rotavirus vaccination into the NIP substantially reduced health and cost outcomes and was cost-effective for both perspectives. However, the government needs to negotiate vaccine price prior to program implementation to achieve favorable budget impact.